Last reviewed · How we verify
NCT06227871
A Retrospective Analysis of Pancreatic Injuries and Treatment Outcomes
trial testing Exploratory laparotomy in Pancreatic Trauma in 31 participants. Completed in 1 March 2023.
1 March 2023
Quick facts
| Lead sponsor | Kern Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 31 |
| Start date | 1 November 2019 |
| Primary completion | 1 March 2023 |
| Estimated completion | 1 March 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Exploratory laparotomy
Conditions studied
- Pancreatic Trauma — all drugs for Pancreatic Trauma →
- Pancreatic Duct Injury — all drugs for Pancreatic Duct Injury →
- Pancreas Necrosis — all drugs for Pancreas Necrosis →
- Pancreas Cyst — all drugs for Pancreas Cyst →
Sponsor
Kern Medical Center
Who can join
18 and older, any sex, with Pancreatic Trauma or Pancreatic Duct Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to compare the presentation, treatment, and outcomes in patients suffering traumatic pancreatic injuries from blunt or penetrating trauma. The questions this study aims to answer are: 1. Does a statistically significant association exist between pancreatic injury grade and the following individual factors: * Mortality * Morbidity * Injury severity score 2. Is there an association between post-operative pancreatic complications and operation-specific intervention? 3. Does pancreatic injury score correlate with certain intra-abdominal organ injuries? Participants meeting criteria are greater than 18 years old, with no history of pancreatic surgery who were hospitalized at Kern Medical Center after presenting to the institution's emergency department as tier 1 or 2 trauma activations following blunt or penetrating abdominal injury and were diagnosed with pancreatic injury during the same hospitalization.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06227871
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Exploratory laparotomy
Trials testing the same drug.
- NCT03490305 — Penetrating Abdominal Injuries From the Battle of Mosul · completed
Other Kern Medical Center trials
Trials by the same sponsor.
- NCT06050161 — Evaluating Artisential Laparoscopic Instruments in Gynecologic Surgery · NA · not yet recruiting
- NCT06197282 — Impact of COVID-19 on Surgical Outcomes · completed
- NCT06135610 — Social Determinants of Health in Patients With Penetrating Trauma Injuries Before and During the COVID-19 Pandemic · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06227871 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kern Medical Center
- Last refreshed: 29 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06227871.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing